(Q38633813)

5 September 2017

1 reference

title

Drug resistance in cancer: an overview of the clinical aspects (English)

1 reference

5 September 2017

Periti P

1

1 reference

PubMed ID

2656931

5 September 2017

Mini E

series ordinal

2

1 reference

5 September 2017

1 February 1989

1 reference

5 September 2017

Journal of Chemotherapy

1 reference

5 September 2017

1

1 reference

5 September 2017

1

1 reference

5 September 2017

5-9

1 reference

Origin of the resistance of leukaemic cells to folic acid antagonists.

5 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

Methotrexate resistant cells as targets for selective chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

Unstable Methotrexate Resistance in Human Small-Cell Carcinoma Associated with Double Minute Chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

Cytosine arabinoside influx and nucleoside transport sites in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

Genetic and biochemical characterization of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

Reversal of drug-resistance in multiple myeloma with verapamil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

Empirical vs. rational approaches in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

Biochemical pharmacology of the lipophilic antifolate, trimetrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738856

10.1080/1120009X.1989.11738856

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

2656931